Companion Canine Health

About Intelligent Therapeutics

Intelligent Therapeutics is a private, preclinical-stage biotech leveraging novel molecular engineering approaches to develop therapeutics for oncology and autoimmune diseases. The company operates a dual pipeline encompassing innovative biologics and biosimilars, indicating a strategy to balance high-risk innovation with lower-risk development. While appearing to be pre-revenue and early-stage, its focus on antibody engineering and expansion into veterinary health presents a diversified approach within the biotech sector.

Therapeutic Areas